Article
Japan's AMED Offers 'Double Match Up' Grants For Pharma Startups: Considerations For Investors And Companies
The Japanese government is aware of the challenges in securing funds for drug development within Japan's biopharmaceutical startup ecosystem, especially compared to Europe and the United States.
Greenberg Traurig, LLP